The success of a pancreas-kidney or pancreas transplant depends on appropriate evaluation of the recipient, expertise in the surgical procedures required to transplant the organs and on-going monitoring after transplant to prevent organ rejection or infections. Pancreas transplantation is reserved for patients who have Type 1 diabetes.
At Cedars-Sinai, we report our data to the United Network for Organ Sharing, a regulatory organization for organ transplants. Information for hospitals in the United States performing transplants is shared with the Scientific Registry of Transplant Recipients, which compares and publishes information about patient characteristics, waiting lists, and outcomes by hospital.
The Cedars-Sinai one-year patient and graft survival data for kidney-pancreas transplant, and the one-year patient survival for pancreas transplant, are presented below, compared to the national estimated survival rate and the rate which would be expected given the characteristic mix of the recipient and donor (age, disease and blood type, etc.) and the experience of similar patients in the U.S.
Simultaneous Pancreas-Kidney Transplants
For the most current period reported, Cedars-Sinai performed more simultaneous pancreas-kidney transplants than any other hospital in Southern California.